Arkolith/Insider Trading/CDMO/Form 4

Kwietniak Matthew R.

Chief Commercial OfficerAvid Bioservices, Inc. (CDMO) · full profile →Form 4 · filed Dec 27, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$164K
Net Open-Market Flow
-$164K
Transactions
14
4 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 26, 2024Sell(S)3K$12.22$39K61K
Dec 26, 2024Sell(S)10K$12.22$124K51K
Dec 25, 2024Option exercise(M)29K——64K
Dec 25, 2024Option exercise(M)9K——35K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 25, 2024Disposed to issuer(D)2K—$072K
Dec 25, 2024Disposed to issuer(D)2K—$070K
Dec 25, 2024Disposed to issuer(D)4K—$066K
Dec 25, 2024Disposed to issuer(D)7K—$0131K
Dec 25, 2024Disposed to issuer(D)7K—$0124K
Dec 25, 2024Disposed to issuer(D)7K—$0110K
Dec 25, 2024Disposed to issuer(D)7K—$0117K
Dec 25, 2024Disposed to issuer(D)16K—$078K
Dec 25, 2024Disposed to issuer(D)16K—$094K
Dec 25, 2024Disposed to issuer(D)1K—$074K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-24-009025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML